First report of outcomes in patients with stage IIIb AL amyloidosis treated with Dara-VCD front-line therapy.
Saved in:
| Title: | First report of outcomes in patients with stage IIIb AL amyloidosis treated with Dara-VCD front-line therapy. |
|---|---|
| Authors: | Chakraborty R; Myeloma/Amyloidosis Program, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York, USA., Rosenbaum C; Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, New York, USA., Kaur G; Harold C. Simmons Comprehensive Cancer Center, Utah Southwestern Medical Center, Dallas, Texas, USA., Bhutani D; Myeloma/Amyloidosis Program, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York, USA., Radhakrishnan J; Division of Nephrology, Columbia University, New York, New York, USA., Mapara MY; Myeloma/Amyloidosis Program, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York, USA., Maurer M; Cardiac Amyloidosis Program, Columbia University Irving Medical Center, New York Presbyterian Hospital, New York, New York, USA., Lentzsch S; Myeloma/Amyloidosis Program, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York, USA. |
| Source: | British journal of haematology [Br J Haematol] 2023 Jun; Vol. 201 (5), pp. 913-916. Date of Electronic Publication: 2023 Mar 10. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36896578 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: First report of outcomes in patients with stage IIIb AL amyloidosis treated with Dara-VCD front-line therapy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Chakraborty+R%22">Chakraborty R</searchLink>; Myeloma/Amyloidosis Program, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Rosenbaum+C%22">Rosenbaum C</searchLink>; Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Kaur+G%22">Kaur G</searchLink>; Harold C. Simmons Comprehensive Cancer Center, Utah Southwestern Medical Center, Dallas, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Bhutani+D%22">Bhutani D</searchLink>; Myeloma/Amyloidosis Program, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Radhakrishnan+J%22">Radhakrishnan J</searchLink>; Division of Nephrology, Columbia University, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Mapara+MY%22">Mapara MY</searchLink>; Myeloma/Amyloidosis Program, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Maurer+M%22">Maurer M</searchLink>; Cardiac Amyloidosis Program, Columbia University Irving Medical Center, New York Presbyterian Hospital, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Lentzsch+S%22">Lentzsch S</searchLink>; Myeloma/Amyloidosis Program, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220372544%22">British journal of haematology</searchLink> [Br J Haematol] 2023 Jun; Vol. 201 (5), pp. 913-916. <i>Date of Electronic Publication: </i>2023 Mar 10. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0372544 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2141 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200071048%22">00071048 </searchLink><i>NLM ISO Abbreviation: </i>Br J Haematol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36896578 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/bjh.18733 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 913 Titles: – TitleFull: First report of outcomes in patients with stage IIIb AL amyloidosis treated with Dara-VCD front-line therapy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Chakraborty R – PersonEntity: Name: NameFull: Rosenbaum C – PersonEntity: Name: NameFull: Kaur G – PersonEntity: Name: NameFull: Bhutani D – PersonEntity: Name: NameFull: Radhakrishnan J – PersonEntity: Name: NameFull: Mapara MY – PersonEntity: Name: NameFull: Maurer M – PersonEntity: Name: NameFull: Lentzsch S IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2023 Jun Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1365-2141 Numbering: – Type: volume Value: 201 – Type: issue Value: 5 Titles: – TitleFull: British journal of haematology Type: main |
| ResultId | 1 |
